Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer - Reply

Stephen G. Chun, Todd A. Pezzi, David Schwartz

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1436-1437
Number of pages2
JournalJAMA Oncology
Volume4
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Combined Modality Therapy
Small Cell Lung Carcinoma

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer - Reply. / Chun, Stephen G.; Pezzi, Todd A.; Schwartz, David.

In: JAMA Oncology, Vol. 4, No. 10, 01.10.2018, p. 1436-1437.

Research output: Contribution to journalLetter

@article{251ca3d400db4f22b43d6aa4152bfe0e,
title = "Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer - Reply",
author = "Chun, {Stephen G.} and Pezzi, {Todd A.} and David Schwartz",
year = "2018",
month = "10",
day = "1",
doi = "10.1001/jamaoncol.2018.3292",
language = "English (US)",
volume = "4",
pages = "1436--1437",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer - Reply

AU - Chun, Stephen G.

AU - Pezzi, Todd A.

AU - Schwartz, David

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85052700135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052700135&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.3292

DO - 10.1001/jamaoncol.2018.3292

M3 - Letter

VL - 4

SP - 1436

EP - 1437

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 10

ER -